Moving Beyond JAK Inhibitors in Myeloproliferative Neoplasms
2 Visningar
• 07/29/23
0
0
Bädda in
administrator
Prenumeranter
Naveen Pemmaraju, MD, discusses the need to move beyond JAK inhibition when treating patients with myeloproliferative neoplasms.
Visa mer
Facebook-kommentarer
SORT BY-
Toppkommentarer
-
Senaste kommentarerna